Evaluating the safety of a rotavirus vaccine: the REST of the story

The Rotavirus Efficacy and Safety Trial (REST) was a blinded, placebo-controlled study of the live pentavalent human-bovine vaccine, RotaTeq® (Merck & Co. Inc., West Point, PA). REST was noteworthy because its primary objective was to evaluate the safety of RotaTeq® with regard to intussusceptio...

Descripción completa

Detalles Bibliográficos
Autores principales: Heyse, Joseph F, Kuter, Barbara J, Dallas, Michael J, Heaton, Penny
Formato: Texto
Lenguaje:English
Publicado: Sage 2008
Materias:
Design
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602609/
https://www.ncbi.nlm.nih.gov/pubmed/18375651
http://dx.doi.org/10.1177/1740774508090507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602609/
https://www.ncbi.nlm.nih.gov/pubmed/18375651
http://dx.doi.org/10.1177/1740774508090507

Ejemplares similares